Santarus Inc
SNTS · Chemicals & Drugs · NASDAQ · in our data April 1, 2004 to December 31, 2013 (9.7 years)
The first trading day in our data for Santarus Inc is April 1, 2004 (its first day in our records, which may be later than its listing and is not its founding). At its peak, on November 29, 2013, the market valued it at $2.2 billion. It left the market when it was bought or merged, last trading at $31.96, -0.7% from its split-adjusted high. Holders got whatever the deal paid, which is not in our price data.
Share prices are adjusted for splits and other share changes, so the high and the last price compare like for like; the peak market value is as it was on the day. The return covers the trading days in our data only: it does not include what holders received, or lost, after the last trade (a merger payout, a bankruptcy), and it does not reach back before 2004. How these numbers are made · Report a data issue.
Play today's Daily DropAlso gone in 2013: Chemicals & Drugs
- Onyx Pharmaceuticals Inc peaked at $9.9 billion
- Maxygen Inc peaked at $5.8 billion
- Verenium Corp peaked at $4.9 billion
- Astex Pharmaceuticals Inc peaked at $1.9 billion
- Savient Pharmaceuticals Inc peaked at $1.6 billion
- Map Pharmaceuticals Inc peaked at $882 million
